Parallel Advisors, LLC Novo Cure LTD Call Options Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding NVCR
# of Institutions
285Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$178 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$158 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$101 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$93.6 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$39.3 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.54B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...